M. Preusser, S. De-ribaupierre, A. Wohrer, S. Erridge, and M. Hegi, Current concepts and management of glioblastoma, Annals of Neurology, vol.91, issue.2, pp.9-21, 2011.
DOI : 10.1002/ana.22425

S. Singh, I. Clarke, M. Terasaki, V. Bonn, and C. Hawkins, Identification of a Cancer Stem Cell in Human Brain Tumors, Cancer Res, vol.63, pp.5821-5828, 2003.

A. Vescovi, R. Galli, and B. Reynolds, Brain tumour stem cells, Nature Reviews Cancer, vol.6, issue.6, pp.425-436, 2006.
DOI : 10.1038/nrc1889

Y. Fuchs and H. Steller, Programmed Cell Death in Animal Development and Disease, Cell, vol.147, issue.4, pp.742-758, 2011.
DOI : 10.1016/j.cell.2011.10.033

L. Oliver, E. Hue, J. Rossignol, G. Bougras, and P. Hulin, Distinct Roles of Bcl-2 and Bcl-Xl in the Apoptosis of Human Bone Marrow Mesenchymal Stem Cells during Differentiation, PLoS ONE, vol.205, issue.5, p.19820, 2011.
DOI : 10.1371/journal.pone.0019820.s007

M. Selvakumaran, R. Amaravadi, I. Vasilevskaya, O. Dwyer, and P. , Autophagy Inhibition Sensitizes Colon Cancer Cells to Antiangiogenic and Cytotoxic Therapy, Clinical Cancer Research, vol.19, issue.11, pp.2995-3007, 2013.
DOI : 10.1158/1078-0432.CCR-12-1542

F. Lefranc and R. Kiss, Autophagy, the Trojan horse to combat glioblastomas, Neurosurgical Focus, vol.20, issue.4, p.7, 2006.
DOI : 10.3171/foc.2006.20.4.4

J. Folkman, Angiogenesis, Annual Review of Medicine, vol.57, issue.1, pp.1-18, 2006.
DOI : 10.1146/annurev.med.57.121304.131306

C. Calabrese, H. Poppleton, M. Kocak, T. Hogg, and C. Fuller, A Perivascular Niche for, Brain Tumor Stem Cells. Cancer Cell, vol.11, pp.69-82, 2007.

C. Patru, L. Romao, P. Varlet, L. Coulombel, and E. Raponi, CD133, CD15/SSEA-1, CD34 or side populations do not resume tumor-initiating properties of long-term cultured cancer stem cells from human malignant glio-neuronal tumors, BMC Cancer, vol.4, issue.5, p.66, 2010.
DOI : 10.1016/j.stem.2009.03.003

URL : https://hal.archives-ouvertes.fr/inserm-00663773

E. Galan-moya, L. Guelte, A. Fernandes, E. Thirant, C. Dwyer et al., Secreted factors from brain endothelial cells maintain glioblastoma stem-like cell expansion through the mTOR pathway, EMBO reports, vol.19, issue.5, pp.470-476, 2011.
DOI : 10.1038/sj.onc.1208311

L. Guelte, A. Galan-moya, E. Dwyer, J. Treps, L. Kettler et al., Semaphorin 3A elevates endothelial cell permeability through PP2A inactivation, Journal of Cell Science, vol.125, issue.17, 2012.
DOI : 10.1242/jcs.108282

C. Thirant, E. Galan-moya, L. Dubois, S. Pinte, and P. Chafey, Differential Proteomic Analysis of Human Glioblastoma and Neural Stem Cells Reveals HDGF as a Novel Angiogenic Secreted Factor, STEM CELLS, vol.30, issue.Pt 1, pp.845-853, 2012.
DOI : 10.1002/stem.1062

B. Weksler, E. Subileau, N. Perriere, P. Charneau, and K. Holloway, Blood-brain barrier-specific properties of a human adult brain endothelial cell line, The FASEB Journal, vol.19, pp.1872-1874, 2005.
DOI : 10.1096/fj.04-3458fje

J. Dwyer, J. Hebda, L. Guelte, A. Galan-moya, E. Smith et al., Glioblastoma Cell-Secreted Interleukin-8 Induces Brain Endothelial Cell Permeability via CXCR2, PLoS ONE, vol.7, issue.9, p.45562, 2012.
DOI : 10.1371/journal.pone.0045562.t001

URL : http://doi.org/10.1371/journal.pone.0045562

D. Discher, D. Mooney, and P. Zandstra, Growth Factors, Matrices, and Forces Combine and Control Stem Cells, Science, vol.324, issue.5935, pp.1673-1677, 2009.
DOI : 10.1126/science.1171643

M. Priault, E. Hue, F. Marhuenda, P. Pilet, and L. Oliver, Differential Dependence on Beclin 1 for the Regulation of Pro-Survival Autophagy by Bcl-2 and Bcl-xL in HCT116 Colorectal Cancer Cells, PLoS ONE, vol.5, issue.1, p.8755, 2010.
DOI : 10.1371/journal.pone.0008755.s006

URL : https://hal.archives-ouvertes.fr/hal-00450958

E. Galan-moya and J. Gavard, Feeding the hungry enemy: An endothelial recipe for glioma stem cells, Cell Cycle, vol.10, issue.15, pp.2403-2404, 2011.
DOI : 10.4161/cc.10.15.16198

D. Meley, C. Bauvy, J. Houben-weerts, P. Dubbelhuis, and M. Helmond, AMP-activated Protein Kinase and the Regulation of Autophagic Proteolysis, Journal of Biological Chemistry, vol.281, issue.46, pp.34870-34879, 2006.
DOI : 10.1074/jbc.M605488200

URL : https://hal.archives-ouvertes.fr/inserm-00158593

B. Levine and R. Ranganathan, Autophagy: Snapshot of the network, Nature, vol.22, issue.7302, pp.38-40, 2010.
DOI : 10.1038/466038a

H. Jiang, E. White, C. Conrad, C. Gomez-manzano, and J. Fueyo, Chapter 13 Autophagy Pathways in Glioblastoma, Methods Enzymol, vol.453, pp.273-286, 2009.
DOI : 10.1016/S0076-6879(08)04013-5

Z. Yang and D. Klionsky, Mammalian autophagy: core molecular machinery and signaling regulation, Current Opinion in Cell Biology, vol.22, issue.2, pp.124-131, 2010.
DOI : 10.1016/j.ceb.2009.11.014

F. Janku, D. Mcconkey, D. Hong, and R. Kurzrock, Autophagy as a target for anticancer therapy, Nature Reviews Clinical Oncology, vol.4, issue.9, pp.528-539, 2011.
DOI : 10.1038/nrclinonc.2011.71

E. Naik, O. Reilly, L. Asselin-labat, M. Merino, D. Lin et al., Destruction of tumor vasculature and abated tumor growth upon VEGF blockade is driven by proapoptotic protein Bim in endothelial cells, The Journal of Experimental Medicine, vol.19, issue.7, pp.1351-1358, 2011.
DOI : 10.1038/nrm2308

T. Caserta, A. Smith, A. Gultice, M. Reedy, and T. Brown, Q-VD-OPh, a broad spectrum caspase inhibitor with potent antiapoptotic properties, APOPTOSIS, vol.8, issue.4, pp.345-352, 2003.
DOI : 10.1023/A:1024116916932

R. Kang, H. Zeh, M. Lotze, and D. Tang, The Beclin 1 network regulates autophagy and apoptosis, Cell Death and Differentiation, vol.122, issue.4, pp.571-580, 2011.
DOI : 10.1038/cdd.2010.191

P. Sini, D. James, C. Chresta, and S. Guichard, Simultaneous inhibition of mTORC1 and mTORC2 by mTOR kinase inhibitor AZD8055 induces autophagy and cell death in cancer cells, Autophagy, vol.6, issue.4, pp.553-554, 2010.
DOI : 10.4161/auto.6.4.11671

D. Benjamin, M. Colombi, C. Moroni, and M. Hall, Rapamycin passes the torch: a new generation of mTOR inhibitors, Nature Reviews Drug Discovery, vol.10, issue.11, pp.868-880, 2011.
DOI : 10.1038/nrd3531

N. Charles, E. Holland, R. Gilbertson, R. Glass, and H. Kettenmann, The brain tumor microenvironment, Glia, vol.162, issue.3, pp.502-514, 2012.
DOI : 10.1002/glia.21264

R. Gilbertson and J. Rich, Making a tumour's bed: glioblastoma stem cells and the vascular niche, Nature Reviews Cancer, vol.11, issue.10, pp.733-736, 2007.
DOI : 10.1038/nrc2246

J. Sneddon, The Contribution of Niche-Derived Factors to the Regulation of Cancer Cells, Methods Mol Biol, vol.568, pp.217-232, 2009.
DOI : 10.1007/978-1-59745-280-9_14

L. Persano, E. Rampazzo, G. Basso, and G. Viola, Glioblastoma cancer stem cells: Role of the microenvironment and therapeutic targeting, Biochemical Pharmacology, vol.85, issue.5, pp.612-622, 2013.
DOI : 10.1016/j.bcp.2012.10.001

A. Eramo, L. Ricci-vitiani, A. Zeuner, R. Pallini, and F. Lotti, Chemotherapy resistance of glioblastoma stem cells, Cell Death and Differentiation, vol.13, issue.7, pp.1238-1241, 2006.
DOI : 10.1084/jem.20040921